Last Updated 1 December 2022.
11 Vaccines Approved for Use in Canada
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
22 trials in 14 countries
-
Medicago
Covifenz- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
6 trials in 6 countries
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
70 trials in 24 countries
-
Moderna
Spikevax Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 38 countries
5 trials in 4 countries
-
Moderna
Spikevax Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
2 trials in 1 country
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 35 countries
3 trials in 5 countries
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
4 trials in 1 country
-
Janssen (Johnson & Johnson)
Jcovden- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
73 trials in 34 countries
-
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 49 countries
6 trials in 1 country
14 Vaccines in Clinical Trials in Canada
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
22 trials in 14 countries
-
Medicago
Covifenz- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
6 trials in 6 countries
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
70 trials in 24 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
-
Providence Therapeutics Holdings Inc.
PTX-COVID19-B- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 2 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
73 trials in 34 countries
-
University of Saskatchewan
COVAC-2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
5 trials in 2 countries
-
VBI Vaccines Inc
VBI-2902a- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Entos Pharmaceuticals Inc
Covigenix VAX-001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
University of Saskatchewan
COVAC-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 3 countries
-
VBI Vaccines Inc
VBI-2901a- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
VBI Vaccines Inc.
VBI-2901e- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
McMaster University
Ad5-triCoV/Mac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
McMaster University
ChAd-triCoV/Mac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country